BDBM3162 2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}oxy)carbonyl]phenyl}carbonyl)-3-hydroxybenzoic acid::Balanol analog 28

SMILES CC1(C)C2CCC1(C)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(O)=O)c(O)c1)C2NC(=O)c1ccc(O)cc1

InChI Key InChIKey=HCDKPFLBNVCSDB-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 3162   

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 80nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 210nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 310nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 310nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 340nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 410nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 3.60E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 2.60E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 2.60E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C zeta type(Human)
Sphinx Laboratories

LigandPNGBDBM3162(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 5.00E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article